ArticleERJ open research2026
Airway smooth muscle in asthma: insights from a transcriptomic meta-analysis.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Asthma reconsidered: a cumulative data perspective on airway smooth muscle.ERJ open research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Airway smooth muscle (ASM) cells are central to bronchoconstriction and airway hyperresponsiveness in asthma, yet a comprehensive view of their transcriptional landscape has been lacking. Methods: We performed a meta-analysis of publicly available transcriptomic datasets comparing ASM cells isolated from individuals with asthma with those from healthy controls. We included studies that met predefined inclusion criteria, comprising primary human ASM cells isolated from 26 asthma and 32 healthy control subjects. Each dataset was analysed separately, followed by meta-analysis of differentially expressed genes (DEGs). Heterogenicity assessment, pathway enrichment and single-sample gene set enrichment analysis were performed. DEGs were further matched with genome-wide association studies (GWASs) of asthma. Results: This study identified 150 genes that were consistently dysregulated in asthma-derived ASM cells, compared with those from healthy controls. Conclusions: To the best of our knowledge, this is the first meta-analysis of ASM transcriptomes to delineate a core set of genes and pathways underlying asthma-related airway remodelling. These findings refine our understanding of ASM-specific molecular networks and may guide targeted therapeutics for asthma in future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.